An FDA AdCom in September recommended against full approval for Ocaliva by a 13-1 vote for the treatment of primary biliary ...

The expanded approval intensifies the rivalry with Jazz Pharmaceuticals, which has previously attempted to block Lumryz’s ...

A Phase IIb/III trial with infants entering their first respiratory syncytial virus (RSV) season met its primary endpoints.

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

Sanofi and Orano Group subsidiary Orano Med have announced a partnership to enhance the development of next-generation RLTs.

TheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (bexagliflozin) to patients in sub-Saharan ...

In the US, diagnosed prevalence is anticipated to increase across all opioid addiction patient segments. Credit: Iryna Imago ...

With less than three weeks until Americans cast their vote, what would healthcare look under a Harris or Trump administration ...

The US FDA has approved AbbVie's VYALEV to treat motor fluctuations in adults with advanced Parkinson's disease (PD).

A potential three-year framework agreement between the Greek government and the pharmaceutical industry, starting at the ...

Lexicon Pharmaceuticals has entered a licensing agreement with Viatris, granting the latter exclusive rights to commercialise ...

After a hearing held on 25 September 2024, the European Patent Office (EPO) affirmed bit.bio’s claim against an anonymous ...